HMGB1:在心血管疾病中细胞死亡途径的多方面的调解者
Yue Shi1, Yixuan Ma2, Rong Wang3
1Department of Physiology, School of Basic Medical Sciences, Xuzhou Medical University, Jiangsu, Xuzhou, 221004, China.
Apoptosis : an international journal on programmed cell death
|September 9, 2025
概括
高流动性组盒1 (HMGB1) 蛋白在心血管疾病 (CVD) 中至关重要,影响细胞死亡途径. 准HMGB1为治疗心血管疾病提供了一个有前途的治疗策略.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,对预期寿命和医疗保健成本产生重大影响.
- 高流动性组盒1 (HMGB1) 是一种多功能蛋白质,与心血管疾病相关的各种细胞死亡机制有关.
- HMGB1的作用从有益的早期免疫反应转变为随着疾病进展而破坏细胞平衡的有害干扰.
研究的目的:
- 阐明高流动性组盒1 (HMGB1) 在心血管疾病发病过程中的复杂作用.
- 研究HMGB1在各种细胞死亡途径中的参与,包括PANoptosis,ferroptosis和efferocytosis.
- 评估针对心血管病理中的HMGB1的治疗潜力.
主要方法:
- 对心血管疾病模型中HMGB1功能的临床前研究和现有文献的审查.
- 分析HMGB1对自和亡之间的平衡的影响.
- 研究HMGB1在细胞平衡和受伤反应中的作用.
主要成果:
- 在进展的心血管疾病中,HMGB1的积累破坏了自和亡之间的平衡.
- 过度的HMGB1与多种细胞死亡类型有关,包括PANoptosis,ferroptosis和efferocytosis.
- 临床前研究证实HMGB1是心血管疾病的可行的治疗点.
结论:
- 了解HMGB1的调节功能是开发针对性心血管治疗的关键.
- 向HMGB1释放和表达在心血管疾病模型中显示出治疗前景.
- 涉及HMGB1的联合治疗策略可以促进心血管疾病治疗.
关键词:
细胞灭亡 (apoptosis) 是一种死亡的过程.自自是一种自的过程.中心发电系统 (CVD) 是一个铁化是铁化的一种.这就是HMGB1的特点.尸体消亡 (necrosis) 是一种致死症.热性灭症 (Pyroptosis) 是一种更多相关视频
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.5K
09:38Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart
Published on: May 19, 2017
13.9K
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
354
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
354
01:17Pathophysiology of Heart Failure
2.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
01:01Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
01:26Coronary Artery Disease II: Pathophysiology
332
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
332
01:31The Intrinsic Apoptotic Pathway
8.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K